Bronte Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-578,313
| Closed | -$3.44M | – | 33 |
|
|
2022
Q2 | $3.44M | Hold |
578,313
| – | – | 0.39% | 24 |
|
|
2022
Q1 | $3.66M | Buy |
578,313
+40,729
| +8% | +$258K | 0.31% | 22 |
|
|
2021
Q4 | $2.1M | Sell |
537,584
-11,252
| -2% | -$44K | 0.14% | 21 |
|
|
2021
Q3 | $2.65M | Hold |
548,836
| – | – | 0.19% | 20 |
|
|
2021
Q2 | $3.51M | Sell |
548,836
-1,843
| -0.3% | -$11.8K | 0.25% | 15 |
|
|
2021
Q1 | $3.46M | Buy |
550,679
+19,169
| +4% | +$120K | 0.39% | 14 |
|
|
2020
Q4 | $3.66M | Hold |
531,510
| – | – | 0.58% | 13 |
|
|
2020
Q3 | $2.05M | Buy |
+531,510
| New | +$2.05M | 0.36% | 12 |
|